Skip to main content

JANE STREET GROUP, LLC

Position in PLX — Protalix BioTherapeutics, Inc.

CIK 1595888 NEW YORK, NY

Position in PLX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$41,986
+$4,355 QoQ
Shares Held
18,020
+3.9% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 101 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PLX Over Time

Shares Held

Position Value (USD)

Derivatives in PLX

reported options exposure · as of Jun 30, 2026
CallValue
$91,569
CallShares
39,300
PutValue
$85,977
PutShares
36,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,363,916,985 across 292 Biotechnology names. PLX ranks #250 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PLX

Export CSV
34 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $85,977 36,900
2026-06-30 $91,569 39,300
2026-06-30 $41,986 18,020
2026-03-31 $68,789 31,700
2026-03-31 $125,860 58,000
2026-03-31 $37,631 17,342
2025-12-31 $521,850 289,917
2025-09-30 $81,030 36,500
2025-03-31 $753,454 294,318
2024-12-31 $213,597 113,616
2024-09-30 $46,870 45,952
2024-06-30 $339,603 290,259
2024-03-31 $36,439 28,921
2023-12-31 $51,308 28,825
2023-06-30 $552,164 276,082
2023-03-31 $83,296 39,665
2022-12-31 $126,340 92,219
2022-09-30 $81,615 78,476
2022-06-30 $91,076 83,556
2022-03-31 $153,920 145,208
2021-12-31 $71,096 85,658
2021-09-30 $54,461 40,949
2021-09-30 $139,251 104,700
2021-09-30 $159,068 119,600
2021-06-30 $60,480 31,665
2021-06-30 $326,992 171,200
2021-06-30 $405,111 212,100
2021-03-31 $85,186 19,100
2021-03-31 $215,542 48,328
2021-03-31 $138,706 31,100
2020-12-31 $80,651 22,218
2020-09-30 $56,738 14,661
2020-06-30 $545,081 143,821
2020-03-31 $118,327 50,352